A circRNA neoantigen vaccine elicits potent antitumor immunity and synergizes with checkpoint blockade in melanoma. Wu P, Ge J, Hou X, Qu H, et al. Cancer Lett 2026;648:218459.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu P, Ge J, Hou X, Qu H, et al. A circRNA neoantigen vaccine elicits potent antitumor immunity and synergizes with checkpoint blockade in melanoma. Cancer Lett 2026;648:218459.
PMID: 41903669